Bionomics Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bionomics Limited with three other companies in this sector in AUSTRALIA : Imugene Limited (2019 sales of 4.54 million Australian Dollars [US$2.76 million] of which 100% was Health technologies), Invion Limited (3.88 million Australian Dollars [US$2.36 million] ), and Oncosil Medical Ltd (3.83 million Australian Dollars [US$2.33 million] ).

Sales Analysis. During the year ended June of 2019, sales at Bionomics Limited were A$4.03 million (US$2.45 million). This is a very small increase of 1.9% versus 2018, when the company's sales were A$3.95 million. Despite this increase, sales are still well below the level achieved in 2017, when Bionomics Limited reported sales of A$18.61 million. Sales of Corporate saw an increase of 2.0% in 2019, from A$200,532.00 to A$204,633.00 . Not all segments of Bionomics Limited experienced an increase in sales in 2019: sales of Drug Discovery and Development fell 41.3% to A$701,486.00 .